APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $284,961 | +27.9% | 3,128 | -7.4% | 0.16% | +19.6% |
| Q1 2023 | $222,813 | -24.7% | 3,378 | -41.0% | 0.14% | -31.7% |
| Q4 2022 | $296,040 | -89.5% | 5,725 | -86.2% | 0.20% | -89.6% |
| Q3 2022 | $2,825,000 | +769.2% | 41,365 | +476.2% | 1.94% | +742.0% |
| Q2 2022 | $325,000 | -7.1% | 7,179 | +4.4% | 0.23% | +4.1% |
| Q1 2022 | $350,000 | -38.6% | 6,879 | -43.0% | 0.22% | -36.6% |
| Q4 2021 | $570,000 | +172.7% | 12,060 | +264.4% | 0.35% | +171.3% |
| Q2 2021 | $209,000 | -11.8% | 3,310 | -40.1% | 0.13% | -15.7% |
| Q1 2021 | $237,000 | -27.5% | 5,523 | -3.4% | 0.15% | -31.7% |
| Q4 2020 | $327,000 | – | 5,718 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |